Figure 1 (Sildenafil For Oral Suspension 1)
Sildenafil Powder, For Suspension
Product Images NDC 69238-1574
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 69238-1574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 9 (Sildenafil For Oral Suspension 10)
Figure 10 (Sildenafil For Oral Suspension 11)
Patient prescribed Sicansti 20 mg to be taken three times a day. Baseline walking distance is 5 meters. There is mention of functional capacity and therapeutic casmy. The remaining text is not available for proper evaluation.*
Figure 11 (Sildenafil For Oral Suspension 12)
Figure 12 (Sildenafil For Oral Suspension 13)
Gh (Sildenafil For Oral Suspension 14)
Figure B (Sildenafil For Oral Suspension 15)
Figure C (Sildenafil For Oral Suspension 16)
Figure D (Sildenafil For Oral Suspension 17)
Figure E (Sildenafil For Oral Suspension 18)
Figure F (Sildenafil For Oral Suspension 19)
Figure 2 (Sildenafil For Oral Suspension 2)
Figure G (Sildenafil For Oral Suspension 20)
1 (Sildenafil For Oral Suspension 21)
This is a description for a medication called "GEFURE". It should be stored below 30°C (86°F) and should be protected from moisture. When reconstituted with 90mL of water, each mL of the suspension contains 10mg of sildenafil (as citrate). The medication comes in a grape flavor and should be shaken well before use. It should not be frozen and any unused portion should be discarded after 60 days. The usual dosage should be seen in the packaging insert for full prescribing information.*
1 (Sildenafil For Oral Suspension 22)
Sildenafil is a medication available in grape-flavored suspension form that is taken orally. Before using, it must be reconstituted by adding water and shaking vigorously; instructions for doing so are included with the medication. Sildenafil is intended for oral use only and should be shaken well prior to each use. Proper storage is important; the medication should be kept below 30°C (86°F), either in the fridge or in its original package until reconstitution. Each mL of the suspension contains 10mg of sildenafil (as citrate) and there is 1.57g of sildenafil citrate (1.12g sildenafil) in each bottle. A dosing syringe and bottle adapter are included with the medication. This medication is distributed by Amneal Pharmaceuticals LLC, located in Bridgewater, NJ, and is available only by prescription. The medication's NDC number is 69238-1574-1. The text includes instructions for reconstitution, as well as dosage and storage information.*
Figure 3 (Sildenafil For Oral Suspension 3)
Figure 4 (Sildenafil For Oral Suspension 4)
Figure 5 (Sildenafil For Oral Suspension 5)
Figure 6 (Sildenafil For Oral Suspension 6)
Structural Formula (Sildenafil For Oral Suspension 7)
Figure- 7 (Sildenafil For Oral Suspension 8)
This is a table displaying drug interactions and recommended adjustments for certain drugs based on fold change and 90% confidence interval. The table lists drugs like Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Reonevit, and Saquinavir. The recommendations regarding dose adjustments and co-administration are strictly mentioned in the table. The last row of the table compares the change in effect of Sildenafil alone and with the interacting drugs mentioned earlier.*
Figure 8 (Sildenafil For Oral Suspension 9)
This text provides recommendations for adjusting doses of various drugs based on their interaction with other drugs. It includes fold change and 90% confidence interval recommendations for several drugs including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir and Tolbutamide. The text also includes dosage adjustment recommendations for some drugs when coadministered with others. The last line refers to a graph displaying the change in drug effectiveness relative to the interacting drug alone.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
